Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5592709 | Cardiovascular Revascularization Medicine | 2017 | 8 Pages |
Abstract
Although several recent studies have challenged traditional expectations regarding the duration of dual antiplatelet therapy, current guidelines recommend at least 6 to 12Â months of treatment after implantation of a drug eluting stent, with a shorter course for bare metal stents. Stent selection ideally should involve input from the patient receiving these stents, but multiple studies have suggested that angiographic factors - obtained after the patient has received sedation during the diagnostic catheterization - are important predictors of repeat revascularization. In this analysis from a large registry of patients receiving coronary stents, angiographic characteristics were found to significantly improve risk assessment for target lesion revascularization, when added to clinical variables alone.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Joshua M. Stolker, David J. Cohen, Kevin F. Kennedy, Michael J. Pencina, Suzanne V. Arnold, Neal S. Kleiman, John A. Spertus, EVENT Investigators EVENT Investigators,